(6,7- dimethoxy- 2,4- dihydroindeno(1,2- c)pyrazol- 3- yl)(3- fluorophenyl)amine
a PDGF receptor tyrosine kinase inhibitor; a PDGF-BB antagonist with both antiangiogenic and antineoplastic activites; structure in first source
Also Known As:
J101 compound; JNJ 10198409; JNJ-10198409; JNJ10198409; RWJ-540973
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Carballo-Santana, Mar:
1 article
(09/2018)
|
2. | Carrasco-Garcia, Estefania:
1 article
(09/2018)
|
3. | Fuentes-Baile, Maria:
1 article
(09/2018)
|
4. | García-Morales, Pilar:
1 article
(09/2018)
|
5. | Martinez-Lacaci, Isabel:
1 article
(09/2018)
|
6. | Mayor-López, Leticia:
1 article
(09/2018)
|
7. | Rodriguez-Lescure, Álvaro:
1 article
(09/2018)
|
8. | Saceda, Miguel:
1 article
(09/2018)
|
9. | Tristante, Elena:
1 article
(09/2018)
|
10. | Ventero Martin, Maria Paz:
1 article
(09/2018)
|
Related Diseases
Related Drugs and Biologics